Murine protein serine-threonine kinase 38 activates p53 function through Ser 15 phosphorylation

Journal of Biological Chemistry

Volumn 287, Issue 25, 2012, Pages 20797-20810

  Seong, Hyun A ^a   Ha, Hyunjung ^a  

^a Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5-FLUOROURACIL; CARBOXYL-TERMINAL DOMAIN; CELL-CYCLE ARREST; DNA-BINDING DOMAIN; DOSE-DEPENDENT MANNER; DOXORUBICIN; ECTOPIC EXPRESSIONS; KINASE FAMILY; MEDIATED TRANSCRIPTION; MURINE PROTEINS; NEGATIVE REGULATORS; NUCLEAR TRANSLOCATIONS; P53 FUNCTION; RECEPTOR-ASSOCIATED PROTEINS; WILD TYPES;

CELL DEATH; ENZYMES; PHOSPHORYLATION; PROTEINS; TRANSCRIPTION;

AMINO ACIDS;

DOXORUBICIN; FLUOROURACIL; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN 14 3 3; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE 38; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; SERINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G0 PHASE; CELL TRANSPORT; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA BINDING MOTIF; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; IN VITRO STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

14-3-3 PROTEINS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; DOXORUBICIN; FLUOROURACIL; HEK293 CELLS; HUMANS; MICE; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84862270330     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.347757     Document Type: Article

References (43)

1. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
2. Prives, C., and Hall, P. A. (1999) The p53 pathway. J. Pathol. 187, 112-126 (Pubitemid 29009841)
3. Appella, E., and Anderson, C. W. (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268, 2764-2772 (Pubitemid 32862957)
4. Shieh, S. Y., Ikeda, M., Taya, Y., and Prives, C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334 (Pubitemid 27467963)
5. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677
6. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (Pubitemid 28435584)
7. Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S. Y., Taya, Y., Prives, C., and Abraham, R. T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-157 (Pubitemid 29061945)
8. 1 by stabilizing p53. Genes Dev. 14, 278-288
9. Shieh, S. Y., Ahn, J., Tamai, K., Taya, Y., and Prives, C. (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289-300 (Pubitemid 30106484)
10. Hirao, A., Kong, Y. Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., and Mak, T. W. (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827
11. Dumaz, N., and Meek, D. W. (1999) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18, 7002-7010 (Pubitemid 30000453)
12. Toledo, F., and Wahl, G. M. (2006) Regulating the p53 pathway. In vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6, 909-923 (Pubitemid 44862676)
13. Gil, M., Yang, Y., Lee, Y., Choi, I., and Ha, H. (1997) Cloning and expression of a cDNA encoding a novel protein serine-threonine kinase predominantly expressed in hematopoietic cells. Gene 195, 295-301 (Pubitemid 27354707)
14. Heyer, B. S., Warsowe, J., Solter, D., Knowles B. B., and Ackerman, S. L. (1997) New member of the Snf1/AMPK kinase family, Melk, is expressed in the mouse egg and preimplantation embryo. Mol. Reprod. Dev. 47, 148-156 (Pubitemid 27188223)
15. Blot, J., Chartrain, I., Roghi, C., Philippe, M., and Tassan, J. P. (2002) Cell cycle regulation of pEg3, a new Xenopus protein kinase of the KIN1/PAR-1/MARK family. Dev. Biol. 241, 327-338 (Pubitemid 34098696)
16. Chartrain, I., Couturier, A., and Tassan, J. P. (2006) Cell cycle-dependent cortical localization of pEg3 protein kinase in Xenopus and human cells. Biol. Cell 98, 253-263
17. Davezac, N., Baldin, V., Blot, J., Ducommun, B., and Tassan, J. P. (2002) Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase. A potential role for pEg3 in cell cycle regulation. Oncogene 21, 7630-7641 (Pubitemid 35398810)
18. Badouel, C., Körner, R., Frank-Vaillant, M., Couturier, A., Nigg, E. A., and Tassan, J. P. (2006) M phase MELK activity is regulated by MPF and MAPK. Cell Cycle 5, 883-889 (Pubitemid 44145585)
19. Beullens, M., Vancauwenbergh, S., Morrice, N., Derua, R., Ceulemans, H., Waelkens, E., and Bollen, M. (2005) Substrate specificity and activity regulation of protein kinase MELK. J. Biol. Chem. 280, 40003-40011 (Pubitemid 41779134)
20. 838 phosphorylation. J. Biol. Chem. 283, 34541-34553
21. Seong, H. A., Jung, H., and Ha, H. (2010) Murine protein serine-threonine kinase 38 stimulates TGF-β signaling in a kinase-dependent manner via direct phosphorylation of Smad proteins. J. Biol. Chem. 285, 30959-30970
22. Jakobsen, S. N., Hardie, D. G., Morrice, N., and Tornqvist, H. E. (2001) 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 276, 46912-46916
23. Jung, H., Seong, H. A., and Ha, H. (2008) Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J. Biol. Chem. 283, 20383-20396
24. Seong, H. A., Jung, H., Choi, H. S., Kim K. T, and Ha, H. (2005) Regulation of transforming growth factor-β signaling and PDK1 kinase activity by physical interaction between PDK1 and serine-threonine kinase receptor-associated protein. J. Biol. Chem. 280, 42897-42908 (Pubitemid 43049252)
25. Seong, H. A., Jung, H., and Ha, H. (2007) NM23-H1 tumor suppressor physically interacts with serine-threonine kinase receptor-associated protein, a transforming growth factor-β (TGF-β) receptor-interacting protein, and negatively regulates TGF-β signaling. J. Biol. Chem. 282, 12075-12096 (Pubitemid 47100716)
26. Jung, H., Seong, H. A., and Ha, H. (2007) NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function. J. Biol. Chem. 282, 35293-35307 (Pubitemid 350232484)
27. Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., and Thompson, C. B. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18, 283-293 (Pubitemid 41350534)
28. Okoshi, R., Ozaki, T., Yamamoto, H., Ando, K., Koida, N., Ono, S., Koda, T., Kamijo, T., Nakagawara, A., and Kizaki, H. (2008) Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J. Biol. Chem. 283, 3979-3987
29. Kato, K., Ogura, T., Kishimoto, A., Minegishi, Y., Nakajima, N., Miyazaki, M., and Esumi, H. (2002) Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 21, 6082-6090
30. Suzuki, A., Kusakai, G., Kishimoto, A., Lu, J., Ogura, T., and Esumi, H. (2003) ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation but not by chemotherapeutic agents or UV irradiation. Oncogene 22, 6177-6182 (Pubitemid 37281647)
31. Suzuki, A., Kusakai, G., Kishimoto, A., Lu, J., Ogura, T., Lavin, M. F., and Esumi, H. (2003) Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J. Biol. Chem. 278, 48-53 (Pubitemid 36043542)
32. Bode, A. M., and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4, 793-805 (Pubitemid 39331151)
33. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245
34. Stavridi, E. S., Chehab, N. H., Malikzay, A., and Halazonetis, T. D. (2001) Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest. Cancer Res. 61, 7030-7033 (Pubitemid 32946490)
35. Seong, H. A., Gil, M., Kim, K. T., Kim, S. J., and Ha, H. (2002) Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine protein serine-threonine kinase 38 (MPK38). Biochem. J. 361, 597-604 (Pubitemid 34177828)
36. Vulsteke, V., Beullens, M., Boudrez, A., Keppens, S., Van Eynde, A., Rider, M. H., Stalmans, W., and Bollen, M. (2004) Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1. J. Biol. Chem. 279, 8642-8647 (Pubitemid 38295919)
37. Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., and Kornblum, H. I. (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U.S.A. 100, 15178-15183 (Pubitemid 37518036)
38. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., and Chinnaiyan, A. M. (2004) Large scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. U.S.A. 101, 9309-9314 (Pubitemid 38812872)
39. Gray, D., Jubb, A. M., Hogue, D., Dowd, P., Kljavin, N., Yi, S., Bai, W., Frantz, G., Zhang, Z., Koeppen, H., de Sauvage, F. J., and Davis, D. P. (2005) Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. Cancer Res. 65, 9751-9761 (Pubitemid 41541452)
40. Vousden, K. H., and Lu, X. (2002) Live or let die. The cell's response to p53. Nat. Rev. Cancer 2, 594-604 (Pubitemid 37328926)
41. Giaccia, A. J., and Kastan, M. B. (1998) The complexity of p53 modulation. emerging patterns from divergent signals. Genes Dev. 12, 2973-2983 (Pubitemid 28469299)
42. Meek, D. W. (1999) Mechanisms of switching on p53. A role for covalent modification? Oncogene 18, 7666-7675
43. Meek, D. W. (2004) The p53 response to DNA damage. DNA Repair 3, 1049-1056